|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-7-20
|
|
pubmed:abstractText |
A previous uncontrolled, open trial of levamisole in patients with limited and slowly spreading vitiligo had shown that new lesions did not develop in 94% of patients after 2-4 months of treatment with the drug.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
153
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
163-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16029343-Adult,
pubmed-meshheading:16029343-Child,
pubmed-meshheading:16029343-Dermatologic Agents,
pubmed-meshheading:16029343-Disease Progression,
pubmed-meshheading:16029343-Double-Blind Method,
pubmed-meshheading:16029343-Female,
pubmed-meshheading:16029343-Humans,
pubmed-meshheading:16029343-Levamisole,
pubmed-meshheading:16029343-Male,
pubmed-meshheading:16029343-Psychometrics,
pubmed-meshheading:16029343-Quality of Life,
pubmed-meshheading:16029343-Severity of Illness Index,
pubmed-meshheading:16029343-Treatment Outcome,
pubmed-meshheading:16029343-Vitiligo
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
|
|
pubmed:affiliation |
Department of Psychiatry, All India Institute of Medical Sciences, New Delhi 110 029, India.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
